Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Dunphy

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Cancer Genetics and Cytogenetics|August 16, 2000
Simultaneous presence of t(2;8)(p12;q24) and t(14;18)(q32;q21) in a B-cell lymphoproliferative disorder with features suggestive of an aggressive variant of splenic marginal-zone lymphomaJ R Batanian, C H Dunphy, J M Richart, et al.
Archives of Pathology & Laboratory Medicine|July 28, 2001
CD30 expression in follicular lymphomaL J Gardner, J M Polski, H L Evans, et al.
Journal of Pediatric Hematology/Oncology|March 3, 1998
Spontaneous resolution of myelodysplastic cytogenetic abnormality developed during the treatment of leukemiaJ Y Chu, J R Batanian, G B Gale, et al.
Head & Neck|November 1, 1996
Changes in quality-of-life scores in a population of patients treated for squamous cell carcinoma of the head and neckE M McDonough, M A Varvares, F R Dunphy, et al.
Leukemia & Lymphoma|May 9, 2001
CD7 and CD56-positive primary effusion lymphoma in a human immunodeficiency virus-negative hostJ M Polskj, H L Evans, L E Grosso, et al.
Head & Neck|December 24, 1997
Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomographyV J Lowe, F R Dunphy, M Varvares, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 21, 1997
Expression of p53 protein in advanced head and neck squamous cell carcinoma before and after chemotherapyC H Dunphy, F R Dunphy, J H Boyd, et al.
Urology|December 1, 1989
Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillanceK I Wishnow, D E Johnson, D A Swanson, et al.
Cancer|April 15, 1997
Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatinF R Dunphy, T L Dunleavy, B R Harrison, et al.
Cancer|May 15, 1997
A phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinomaF R Dunphy, J H Boyd, H J Kim, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Cancer Genetics and Cytogenetics|August 16, 2000
Simultaneous presence of t(2;8)(p12;q24) and t(14;18)(q32;q21) in a B-cell lymphoproliferative disorder with features suggestive of an aggressive variant of splenic marginal-zone lymphomaJ R Batanian, C H Dunphy, J M Richart, et al.
Archives of Pathology & Laboratory Medicine|July 28, 2001
CD30 expression in follicular lymphomaL J Gardner, J M Polski, H L Evans, et al.
Journal of Pediatric Hematology/Oncology|March 3, 1998
Spontaneous resolution of myelodysplastic cytogenetic abnormality developed during the treatment of leukemiaJ Y Chu, J R Batanian, G B Gale, et al.
Head & Neck|November 1, 1996
Changes in quality-of-life scores in a population of patients treated for squamous cell carcinoma of the head and neckE M McDonough, M A Varvares, F R Dunphy, et al.
Leukemia & Lymphoma|May 9, 2001
CD7 and CD56-positive primary effusion lymphoma in a human immunodeficiency virus-negative hostJ M Polskj, H L Evans, L E Grosso, et al.
Head & Neck|December 24, 1997
Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomographyV J Lowe, F R Dunphy, M Varvares, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 21, 1997
Expression of p53 protein in advanced head and neck squamous cell carcinoma before and after chemotherapyC H Dunphy, F R Dunphy, J H Boyd, et al.
Urology|December 1, 1989
Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillanceK I Wishnow, D E Johnson, D A Swanson, et al.
Cancer|April 15, 1997
Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatinF R Dunphy, T L Dunleavy, B R Harrison, et al.
Cancer|May 15, 1997
A phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinomaF R Dunphy, J H Boyd, H J Kim, et al.
Pageof 8